Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
1992-5-26
|
| pubmed:abstractText |
After kidney transplantation 1-3.6% of patients develop tuberculosis. At early diagnosis and addressly applied treatment the disease is not life threatening. On the basis of the author's own experience and literary data, suitable combinations of antituberculotics are recommended. At normal or reduced function of the kidney transplant a combination of isoniazid, rifampicin, and pyrazinamide is advocated. In deranged liver function the combination of choice consists of isoniazid, streptomycin, and ethambutol. (Ref. 9).
|
| pubmed:language |
cze
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0006-9248
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
92
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
510-1
|
| pubmed:dateRevised |
2009-11-11
|
| pubmed:meshHeading | |
| pubmed:year |
1991
|
| pubmed:articleTitle |
[Treatment with antitubercular agents after kidney transplantation].
|
| pubmed:affiliation |
III. interní výzkumná základna Institutu klinické a experimentální mediciny v Praze-Krci.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|